SlideShare a Scribd company logo
How Old is Too Old? Age, Genetics and Reproduction Marcelle I. Cedars, M.D. Director, Division of Reproductive Endocrinology UCSF
What is Reproductive Aging? Quantity:  Natural process of oocyte loss Fourth month of fetal development 6-7 million Birth 1-2 million Menarche 400,000 Loss acceleration (approx. age 37) 25,000 Menopause 1000 Process:  Apoptosis
 
What is Reproductive Aging? Quality:  decreased implantation potential Increase in meiotic non-disjunction “ Production-line” theory Accumulated damage Deficiencies of the granulosa cells
Reproductive Aging:  Why do we care?  Changing Demographics   20% of women wait until they are at least 35 years of age before having their first child Establishment of a career Awaiting a stable relationship Desire for financial security False sense of security provided by high-tech fertility procedures
 
Normal Biological Decline  Gougeon, Maturitas, 30:137-142, 1998
Percent Increase in Birthrates CDC Vital and Health Statistics 2000 1976 1980 1985 1990 1995 35-39 30-34 40+ 15-19 25-29 20-24
 
Concurrent Loss in Quantity AND Quality
Oocyte Quality Chromosomes and DNA Mitochondria and ooplasm
Abnormalities in oocytes increase with age
 
Impact of Genetics  on Ovarian Aging Complex Trait Genetic Familial association with age at menopause 30-85% estimates of heritability Environmental  Oxidative stress Alterations in blood flow Toxins in the environment
 
Reproductive Aging Lifestyle Factors Cigarette smoking Female Affect the follicular microenvironment Affect hormonal levels of the luteal phase Accelerates oocyte loss (menopause 1-4 years earlier) Male Negative affect on sperm production, motility and morphology Increased risk for DNA damage
Reproductive Aging Lifestyle Factors Weight:  BMI < 20 or > 25 Female Alterations in hormonal profile and anovulation Increased time to conception Male Increased time to conception
Reproductive Aging Lifestyle Factors Stress Lack of clear evidence Difficult to measure Some reduction with ART outcome noted Caffeine Studies with problems of recall bias Suggestion of association with reduced fertility Alcohol Studies with problems of recall bias Biological plausibility
Reproductive Aging Lifestyle Factors Environmental Factors Organic solvents Pesticides Phthalates
Loss of Ooctye Quality Abnormal fertilization, arrest of early development Failure to implant Post-implantation problems recognized loss developmentally delayed child (down syndrome)
Assessing Reproductive Age What are you measuring? And Why? Reproductive performance Response to stimulation Live-born
Assessing Reproductive Age Direct measures AFC/ovarian volume Anti-mullerian Hormone (AMH) Inhibin B Indirect measures FSH
Reproductive Aging Is it Quantity or Quality FSH Indirect measure of follicular pool Decrease in inhibin B leads to increase FSH Not associated with increased risk of aneuploidy (vanMongfrans, 2004) Decreased predictive ability in populations with a low prevalence (young women)
Antral follicle count Cycle day Follicle size <  3 – diminished reserve Evaluation of the Ovary Testing of Ovarian Reserve
Antral follicle count AFC = 18 AFC= 4
How to identify  age-related  problems? Body as “bioassay” Shortened menstrual cycles Pre-cycle spotting
 
Ovarian Reserve Testing Goal: To determine the functional capacity of the ovary.  Specifically the quantity and quality of oocytes remaining. General Population Chance of conception Determine the time before  ovarian aging begins Sub-fertile Population Chance of conception, with or without treatment Optimal dose or protocol for treatment Maheshwari, et al, 2006
Does Quantity = Quality? Quantity    number of oocytes retrieved Allows for selection Allows for freezing Affect on pregnancy rate/retrieval BUT does quantity = quality?? Quality Pregnancy rate Surrogate marker:  Implantation rate per embryo transferred
Does Quantity = Quality? Markers of ovarian reserve, such as basal AMH or FSH levels and AFCs, can predict quantity of oocytes, but are not good predictors of oocyte quality (defined as pregnancy success).
FSH Predicts Quantity,  but not Quality P=0.3 P=0.05 P=0.06 P=0.01
AFC Predicts Quantity  and Quality p=0.014 p=0.048 p<0.001 p<0.001
Age  is the Best  Predictor of Quality IR = 28.4 IR = 15.9 p<0.001 PR = 28.7 PR = 46.7 p<0.001
Quantity and Quality IR 21.6% 22.6% P=0.78 IR   Poor Responders 38.9% 14.5% P = 0.001
Decreased AFC 10 20 30 40 AFC Age # Follicles Reproductive window
Reproductive Aging Treatment Counsel couple Likelihood for success Prepare treatment schedule Stimulation based on ovarian (not chronological ) age
 
Stimulations for Advanced Reproductive Aging High dose protocols Flare protocols Halt protocols Antagonist protocols What’s new? Estradiol priming Minimal stimulation Androgen pretreatment
Estradiol Priming Goal: syncrhonize recruitment by preventing the premenstrual rise of FSH
Estradiol Priming addition of luteal phase GnRH antagonist
Minimal Stimulation Cancellation of a short treatment cycle is not a great burden.. Few oocytes is not bad at all.. Quality  is more important than  Quantity . Less oocytes means less burden at aspiration… Mild stimulation cycles have a higher repeat rate…
Minimal Stimulation
Minimal Stimulation Stimulation Mild: closed Conventional: open
Androgen Pretreatment Role of androgens in follicular development Precursors for ovarian estrogen synthesis Augmentation of granulosa cell FSH receptor expression Stimulate IGF-I and IGF-I receptor in preantral and antral follicles Aromatase inhibitors Transdermal testosterone DHEA
Androgen Pretreatment Balasch et al., 2006 Transdermal testosterone 2.5mg over 5 days
 
 
What to do? Early complete infertility evaluation including testing of ovarian reserve Limit treatment recommendations to 3-4 months Improve endocrine environment/increase  egg number
 
 
IVF – Pregnancy and Livebirth CDC 2004
Decide What Is Important Having a child to raise Being pregnant Sharing genetic make-up with partner
Oocyte Donation Candidates diminished ovarian reserve premature ovarian failure genetic problems Success rate 50-60%/cycle 70-90% cumulative Provides evidence that the age of the egg, NOT the uterus, is the critical factor
The Bottom Line Evaluate early Give a fair estimate of outcome Develop a time-limited treatment plan
Thank you for your attention

More Related Content

PPT
Ovaries.ppt
PPTX
The ovarian cycle
PPTX
Menstrual Cycle | Hormonal Regulation
PDF
Reproductive physiology
PPTX
Spermatogenesis
PPTX
Physiology of parturition
PPTX
Spermatogenesis
Ovaries.ppt
The ovarian cycle
Menstrual Cycle | Hormonal Regulation
Reproductive physiology
Spermatogenesis
Physiology of parturition
Spermatogenesis

What's hot (20)

PPT
Ovarian cycle
PPTX
Female reproductive system
PPTX
The menstrual cycle
PPTX
Antomy of scrotum and testis
PPT
FEMALE REPRODUCTIVE HORMONES
PPT
Menstrual Cycle
PPTX
Hypothalamus
PPTX
Progesterone hormone.
PPTX
Ovarian hormones-Estrogen & Progesterone
PPT
Male reproductive system
PPT
puberty - hormonal and physiological changes
PPTX
Anatomy Of Urinary Bladder
PPTX
Human chorionic gonadotropin HCG.
PPT
Anti Diuretic Hormone(ADH).ppt
PPTX
Adrenal gland physiology
PPTX
PPTX
Fertilization
PPTX
Male reproductive physiology
PPT
Male repro epididymis vas seminal vescile
PPTX
The male sexual act
Ovarian cycle
Female reproductive system
The menstrual cycle
Antomy of scrotum and testis
FEMALE REPRODUCTIVE HORMONES
Menstrual Cycle
Hypothalamus
Progesterone hormone.
Ovarian hormones-Estrogen & Progesterone
Male reproductive system
puberty - hormonal and physiological changes
Anatomy Of Urinary Bladder
Human chorionic gonadotropin HCG.
Anti Diuretic Hormone(ADH).ppt
Adrenal gland physiology
Fertilization
Male reproductive physiology
Male repro epididymis vas seminal vescile
The male sexual act
Ad

Similar to Ovary Function (20)

PPT
Infertility.(By Craig)
PDF
New Perspectives : Unexplained infertility 2018
PPTX
HOW TO OPTIMIZE ART OUTCOME
PPT
Dhea jdr
PPT
Fertility Options: IVF Overview
PPTX
HOW TO PREPARE A PATIET FOR IVF.pptx
PPT
Induction Lecture Fmdrl
PPT
Ovarian reserve laboratory diagnosis
PPTX
Recurrant Implantation Failure in IVF
PPTX
Preterm labor: Update 2014
PPTX
IVF: Ways to improve pregnancy rates
PPTX
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
PPTX
RHG Congress 2018 - Richard A Anderson
PPT
Infertility2
PDF
#IVF to #Fit all #Pockets
PPTX
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
PPT
Seminar Presentation Molina Dayal MD 9-13
PPTX
Are we giving much importance to AMH in infertility practice?
PDF
Challenging scenarios in infertility
Infertility.(By Craig)
New Perspectives : Unexplained infertility 2018
HOW TO OPTIMIZE ART OUTCOME
Dhea jdr
Fertility Options: IVF Overview
HOW TO PREPARE A PATIET FOR IVF.pptx
Induction Lecture Fmdrl
Ovarian reserve laboratory diagnosis
Recurrant Implantation Failure in IVF
Preterm labor: Update 2014
IVF: Ways to improve pregnancy rates
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
RHG Congress 2018 - Richard A Anderson
Infertility2
#IVF to #Fit all #Pockets
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Seminar Presentation Molina Dayal MD 9-13
Are we giving much importance to AMH in infertility practice?
Challenging scenarios in infertility
Ad

More from guest7f0a3a (20)

PPT
Recent Trends In Art (2)
PPT
Ivm Of Oocytes Study (1)
PDF
PPT
Ivm Of Oocytes Study
PPT
Ivm Implementation Mnzava
PPT
Ivm Medi Cult 03 07 V2
PPT
Jensen Sterilitaet
PPT
Ov Function Shoham
PPT
Jensen Sterilitaet (1)
PPT
New Developments In Reproductive Medicine
PPT
Ov Function Shoham (1)
PPT
Wheeler
PPT
Recent Trends In Art
PPT
Presentation Marcelle
PPT
Recent Trends In Art (1)
PPT
Ultrasound
PPT
Ultrasound (1)
PPT
Unexplained Infertility
PPT
Unexplained Infertility (1)
PPT
Presentation Marcelle
Recent Trends In Art (2)
Ivm Of Oocytes Study (1)
Ivm Of Oocytes Study
Ivm Implementation Mnzava
Ivm Medi Cult 03 07 V2
Jensen Sterilitaet
Ov Function Shoham
Jensen Sterilitaet (1)
New Developments In Reproductive Medicine
Ov Function Shoham (1)
Wheeler
Recent Trends In Art
Presentation Marcelle
Recent Trends In Art (1)
Ultrasound
Ultrasound (1)
Unexplained Infertility
Unexplained Infertility (1)
Presentation Marcelle

Recently uploaded (20)

PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPTX
Morphology of Bacterial Cell for bsc sud
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPTX
antibiotics rational use of antibiotics.pptx
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
Reading between the Rings: Imaging in Brain Infections
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
Anatomy and physiology of the digestive system
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
the psycho-oncology for psychiatrists pptx
PDF
TISSUE LECTURE (anatomy and physiology )
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Post Op complications in general surgery
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
Morphology of Bacterial Cell for bsc sud
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
Copy of OB - Exam #2 Study Guide. pdf
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
antibiotics rational use of antibiotics.pptx
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Reading between the Rings: Imaging in Brain Infections
nephrology MRCP - Member of Royal College of Physicians ppt
Anatomy and physiology of the digestive system
y4d nutrition and diet in pregnancy and postpartum
the psycho-oncology for psychiatrists pptx
TISSUE LECTURE (anatomy and physiology )
Electrolyte Disturbance in Paediatric - Nitthi.pptx
CHEM421 - Biochemistry (Chapter 1 - Introduction)
neurology Member of Royal College of Physicians (MRCP).ppt
Post Op complications in general surgery

Ovary Function

  • 1. How Old is Too Old? Age, Genetics and Reproduction Marcelle I. Cedars, M.D. Director, Division of Reproductive Endocrinology UCSF
  • 2. What is Reproductive Aging? Quantity: Natural process of oocyte loss Fourth month of fetal development 6-7 million Birth 1-2 million Menarche 400,000 Loss acceleration (approx. age 37) 25,000 Menopause 1000 Process: Apoptosis
  • 3.  
  • 4. What is Reproductive Aging? Quality: decreased implantation potential Increase in meiotic non-disjunction “ Production-line” theory Accumulated damage Deficiencies of the granulosa cells
  • 5. Reproductive Aging: Why do we care? Changing Demographics 20% of women wait until they are at least 35 years of age before having their first child Establishment of a career Awaiting a stable relationship Desire for financial security False sense of security provided by high-tech fertility procedures
  • 6.  
  • 7. Normal Biological Decline Gougeon, Maturitas, 30:137-142, 1998
  • 8. Percent Increase in Birthrates CDC Vital and Health Statistics 2000 1976 1980 1985 1990 1995 35-39 30-34 40+ 15-19 25-29 20-24
  • 9.  
  • 10. Concurrent Loss in Quantity AND Quality
  • 11. Oocyte Quality Chromosomes and DNA Mitochondria and ooplasm
  • 12. Abnormalities in oocytes increase with age
  • 13.  
  • 14. Impact of Genetics on Ovarian Aging Complex Trait Genetic Familial association with age at menopause 30-85% estimates of heritability Environmental Oxidative stress Alterations in blood flow Toxins in the environment
  • 15.  
  • 16. Reproductive Aging Lifestyle Factors Cigarette smoking Female Affect the follicular microenvironment Affect hormonal levels of the luteal phase Accelerates oocyte loss (menopause 1-4 years earlier) Male Negative affect on sperm production, motility and morphology Increased risk for DNA damage
  • 17. Reproductive Aging Lifestyle Factors Weight: BMI < 20 or > 25 Female Alterations in hormonal profile and anovulation Increased time to conception Male Increased time to conception
  • 18. Reproductive Aging Lifestyle Factors Stress Lack of clear evidence Difficult to measure Some reduction with ART outcome noted Caffeine Studies with problems of recall bias Suggestion of association with reduced fertility Alcohol Studies with problems of recall bias Biological plausibility
  • 19. Reproductive Aging Lifestyle Factors Environmental Factors Organic solvents Pesticides Phthalates
  • 20. Loss of Ooctye Quality Abnormal fertilization, arrest of early development Failure to implant Post-implantation problems recognized loss developmentally delayed child (down syndrome)
  • 21. Assessing Reproductive Age What are you measuring? And Why? Reproductive performance Response to stimulation Live-born
  • 22. Assessing Reproductive Age Direct measures AFC/ovarian volume Anti-mullerian Hormone (AMH) Inhibin B Indirect measures FSH
  • 23. Reproductive Aging Is it Quantity or Quality FSH Indirect measure of follicular pool Decrease in inhibin B leads to increase FSH Not associated with increased risk of aneuploidy (vanMongfrans, 2004) Decreased predictive ability in populations with a low prevalence (young women)
  • 24. Antral follicle count Cycle day Follicle size < 3 – diminished reserve Evaluation of the Ovary Testing of Ovarian Reserve
  • 25. Antral follicle count AFC = 18 AFC= 4
  • 26. How to identify age-related problems? Body as “bioassay” Shortened menstrual cycles Pre-cycle spotting
  • 27.  
  • 28. Ovarian Reserve Testing Goal: To determine the functional capacity of the ovary. Specifically the quantity and quality of oocytes remaining. General Population Chance of conception Determine the time before ovarian aging begins Sub-fertile Population Chance of conception, with or without treatment Optimal dose or protocol for treatment Maheshwari, et al, 2006
  • 29. Does Quantity = Quality? Quantity  number of oocytes retrieved Allows for selection Allows for freezing Affect on pregnancy rate/retrieval BUT does quantity = quality?? Quality Pregnancy rate Surrogate marker: Implantation rate per embryo transferred
  • 30. Does Quantity = Quality? Markers of ovarian reserve, such as basal AMH or FSH levels and AFCs, can predict quantity of oocytes, but are not good predictors of oocyte quality (defined as pregnancy success).
  • 31. FSH Predicts Quantity, but not Quality P=0.3 P=0.05 P=0.06 P=0.01
  • 32. AFC Predicts Quantity and Quality p=0.014 p=0.048 p<0.001 p<0.001
  • 33. Age is the Best Predictor of Quality IR = 28.4 IR = 15.9 p<0.001 PR = 28.7 PR = 46.7 p<0.001
  • 34. Quantity and Quality IR 21.6% 22.6% P=0.78 IR  Poor Responders 38.9% 14.5% P = 0.001
  • 35. Decreased AFC 10 20 30 40 AFC Age # Follicles Reproductive window
  • 36. Reproductive Aging Treatment Counsel couple Likelihood for success Prepare treatment schedule Stimulation based on ovarian (not chronological ) age
  • 37.  
  • 38. Stimulations for Advanced Reproductive Aging High dose protocols Flare protocols Halt protocols Antagonist protocols What’s new? Estradiol priming Minimal stimulation Androgen pretreatment
  • 39. Estradiol Priming Goal: syncrhonize recruitment by preventing the premenstrual rise of FSH
  • 40. Estradiol Priming addition of luteal phase GnRH antagonist
  • 41. Minimal Stimulation Cancellation of a short treatment cycle is not a great burden.. Few oocytes is not bad at all.. Quality is more important than Quantity . Less oocytes means less burden at aspiration… Mild stimulation cycles have a higher repeat rate…
  • 43. Minimal Stimulation Stimulation Mild: closed Conventional: open
  • 44. Androgen Pretreatment Role of androgens in follicular development Precursors for ovarian estrogen synthesis Augmentation of granulosa cell FSH receptor expression Stimulate IGF-I and IGF-I receptor in preantral and antral follicles Aromatase inhibitors Transdermal testosterone DHEA
  • 45. Androgen Pretreatment Balasch et al., 2006 Transdermal testosterone 2.5mg over 5 days
  • 46.  
  • 47.  
  • 48. What to do? Early complete infertility evaluation including testing of ovarian reserve Limit treatment recommendations to 3-4 months Improve endocrine environment/increase egg number
  • 49.  
  • 50.  
  • 51. IVF – Pregnancy and Livebirth CDC 2004
  • 52. Decide What Is Important Having a child to raise Being pregnant Sharing genetic make-up with partner
  • 53. Oocyte Donation Candidates diminished ovarian reserve premature ovarian failure genetic problems Success rate 50-60%/cycle 70-90% cumulative Provides evidence that the age of the egg, NOT the uterus, is the critical factor
  • 54. The Bottom Line Evaluate early Give a fair estimate of outcome Develop a time-limited treatment plan
  • 55. Thank you for your attention